| Characteristic |
N=339 n (%) |
| Gender |
|
| Female |
223 (65.8) |
| Male |
116 (34.2) |
| Age (years) |
|
| ≤ 40 |
173 (51.0) |
| >40 |
166 (49.0) |
| Marital status |
|
| Married |
201 (59.3) |
| Single |
46 (13.6) |
| Separated/divorced |
22 (6.5) |
| Widowed |
70 (20.6) |
| Educational status |
|
| None/Primary |
91 (26.9) |
| Secondary |
158 (46.6) |
| Tertiary |
90 (26.5) |
| Residence |
|
| Urban |
191 (56.3) |
| Rural |
148 (43.7) |
| Household income (Naira) |
|
| <20,000 |
186 (54.9) |
| 20-50,000 |
73 (21.5) |
| 51-100,000 |
50 (14.7) |
| >100,000 |
30 (8.8) |
| Household size/No of dependents |
|
| ≤4 |
114 (34.3) |
| 8-May |
158 (47.6) |
| >8 |
60 (18.1) |
| People per room |
|
| ≤2 |
241 (71.1) |
| >2 |
98 (28.9) |
| Socio-economic class |
|
| Upper (class I) |
27 (8.0) |
| Middle (class II & III) |
141 (41.6) |
| Lower (class IV & V) |
171 (50.4) |
| Duration of HIV diagnosis (years), median (IQR) |
3.4 (2.0-6.0) |
| HAART duration (months), median (IQR) |
35.0 (20.0-50.0) |
| HAART adherence, n (%) |
263 (77.6) |
| Baseline WHO clinical stage |
|
| 1-2 |
245 (72.3) |
| 3-4 |
94 (27.7) |
| Baseline CD4 cell count (cells/µL) |
|
| <200 |
168 (49.6) |
| 200-499 |
159 (46.9) |
| ≥500 |
12 (3.5) |
| Current CD4 cell count (cells/µL) |
|
| <200 |
75 (22.1) |
| 200-499 |
180 (53.1) |
| ≥500 |
84 (24.8) |
| Baseline hemoglobin (g/dl), mean ± SD |
11.2 ± 2.0 |
| Current hemoglobin (g/dl), mean ± SD |
11.6 ± 1.8 |
HAART= Highly Active Antiretroviral Therapy; HIV=Human Immunodeficiency Virus;
IQR= Interquartile Range; SD= Standard Deviation; WHO= World Health Organization |
